ArticleEuropean radiology2025
Long-term prognostic value of the CT-derived fractional flow reserve combined with atherosclerotic burden in patients with non-obstructive coronary artery disease.
Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Multiparametric Coronary CT Angiography-Derived Imaging Biomarkers for Risk Stratification in Nonobstructive Coronary Artery Disease: Incremental Prognostic Value in Patients with Diabetes.Tomography (Ann Arbor, Mich.) · 2026Article
- A Pathophysiology-Oriented Imaging Phenotype Framework for Nonobstructive Coronary Artery Disease.Journal of cardiovascular development and disease · 2026Article
- Current State of Computed Tomography Derived Fractional Flow Reserve (FFR-CT) and Its Diagnostic Advantages.Clinical Medicine Insights. Cardiology · 2026Review
- Cardiac CT in Non-Obstructive Coronary Artery Disease (NOCAD): A Literature Review.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesThe long-term prognostic significance of the coronary computed tomography angiography (CCTA)-derived fractional flow reserve (CT-FFR) for non-obstructive coronary artery disease (CAD) is uncertain. We aimed to investigate the additional prognostic value of CT-FFR beyond CCTA-defined atherosclerotic burden for long-term outcomes. MATERIALS AND
methodsConsecutive patients with suspected stable CAD were candidates for this retrospective cohort study. Deep-learning-based vessel-specific CT-FFR was calculated. All patients enrolled were followed for at least 5 years. The primary outcome was major adverse cardiovascular events (MACE). Predictive abilities for MACE were compared among three models (model 1, constructed using clinical variables; model 2, model 1 + CCTA-derived atherosclerotic burden (Leiden risk score and segment involvement score); and model 3, model 2 + CT-FFR).
resultsA total of 1944 patients (median age, 59 (53-65) years; 53.0% men) were included. During a median follow-up time of 73.4 (71.2-79.7) months, 64 patients (3.3%) experienced MACE. In multivariate-adjusted Cox models, CT-FFR ≤ 0.80 (HR: 7.18; 95% CI: 4.25-12.12; p < 0.001) was a robust and independent predictor for MACE. The discriminant ability was higher in model 2 than in model 1 (C-index, 0.76 vs. 0.68; p = 0.001) and was further promoted by adding CT-FFR to model 3 (C-index, 0.83 vs. 0.76; p < 0.001). Integrated discrimination improvement (IDI) was 0.033 (p = 0.022) for model 2 beyond model 1. Of note, compared with model 2, model 3 also exhibited improved discrimination (IDI = 0.056; p < 0.001).
conclusionsIn patients with non-obstructive CAD, CT-FFR provides robust and incremental prognostic information for predicting long-term outcomes. The combined model including CT-FFR and CCTA-defined atherosclerotic burden exhibits improved prediction abilities, which is helpful for risk stratification. KEY POINTS: Question Prognostic significance of the CT-fractional flow reserve (FFR) in non-obstructive coronary artery disease for long-term outcomes merits further investigation. Findings Our data strongly emphasized the independent and additional predictive value of CT-FFR beyond coronary CTA-defined atherosclerotic burden and clinical risk factors. Clinical relevance The new combined predictive model incorporating CT-FFR can be satisfactorily used for risk stratification of patients with non-obstructive coronary artery disease by identifying those who are truly suitable for subsequent high-intensity preventative therapies and extensive follow-up for prognostic reasons.
Indexed as
Identifiers
40514597What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.